Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A

Autophagy. 2023 Feb;19(2):678-691. doi: 10.1080/15548627.2022.2093028. Epub 2022 Jul 15.

Abstract

BCL2: BCL2 apoptosis regulator; BCL10: BCL10 immune signaling adaptor; CARD11: caspase recruitment domain family member 11; CBM: CARD11-BCL10-MALT1; CR2: complement C3d receptor 2; EBNA: Epstein Barr nuclear antigen; EBV: Epstein-Barr virus; FCGR3A; Fc gamma receptor IIIa; GLILD: granulomatous-lymphocytic interstitial lung disease; HV: healthy volunteer; IKBKB/IKB kinase: inhibitor of nuclear factor kappa B kinase subunit beta; IL2RA: interleukin 2 receptor subunit alpha; MALT1: MALT1 paracaspase; MS4A1: membrane spanning 4-domain A1; MTOR: mechanistic target of rapamycin kinase; MYC: MYC proto-oncogene, bHLH: transcription factor; NCAM1: neural cell adhesion molecule 1; NFKB: nuclear factor kappa B; NIAID: National Institute of Allergy and Infectious Diseases; NK: natural killer; PTPRC: protein tyrosine phosphatase receptor type C; SELL: selectin L; PBMCs: peripheral blood mononuclear cells; TR: T cell receptor; Tregs: regulatory T cells; WT: wild-type.

Keywords: ATG9A; MTOR; NFKB; T-cell signaling; cellular proliferation; rapamycin.

Publication types

  • Case Reports
  • Research Support, N.I.H., Intramural
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy
  • Autophagy-Related Proteins / genetics
  • Epstein-Barr Virus Infections*
  • Herpesvirus 4, Human
  • Humans
  • Hyperplasia
  • Leukocytes, Mononuclear / metabolism
  • Membrane Proteins / genetics
  • Mutation
  • NF-kappa B / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Vesicular Transport Proteins / genetics

Substances

  • ATG9A protein, human
  • Autophagy-Related Proteins
  • Membrane Proteins
  • NF-kappa B
  • Proto-Oncogene Proteins c-bcl-2
  • Vesicular Transport Proteins